ADAM33 and neoplasm: We compared the results of the DEGs to the ASE gene analysis to identify four overlapped genes: MCL1, SLC43A2, PDE3B, and ADAM33. As a tumor disease, gene functional validation was conducted not only in CD4+ T cells but also in tumor tissues, which could provide powerful evidence of key genes responding to MDV resistance.